Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
de Heer EC, Zois CE, Bridges E, van der Vegt B, Sheldon H, Veldman WA, Zwager MC, van der Sluis T, Haider S, Morita T, Baba O, Schröder CP, de Jong S, Harris AL, Jalving M.
de Heer EC, et al. Among authors: van der sluis t, van der vegt b.
J Exp Clin Cancer Res. 2023 Aug 28;42(1):220. doi: 10.1186/s13046-023-02800-3.
J Exp Clin Cancer Res. 2023.
PMID: 37635223
Free PMC article.
No abstract available.